Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Kanako Nishiyama"'
Autor:
Kana Taguchi, PhD, Yoshiaki Kamei, PhD, Erina Kusakabe, MD, Michiko Yamashita, PhD, Haruna Noda, MD, Reina Aoki, MD, Kanako Nishiyama, MD, Akari Murakami, PhD, Hiroaki Tanaka, PhD, Megumi Matsuda, PhD, Teruhito Kido, PhD, Norio Sato, PhD, Yasutsugu Takada, PhD
Publikováno v:
Radiology Case Reports, Vol 17, Iss 5, Pp 1737-1740 (2022)
A non-traumatic abdominal wall hematoma is rare, and occurs occasionally due to coughing, physical activity, or antithrombotic/anticoagulant therapy. The condition is usually unilateral; however, rare bilateral cases have been reported. Here, we repo
Externí odkaz:
https://doaj.org/article/48012c60f97f4e3ba2ddd32a31c341c0
Autor:
Haruna Noda, Michiko Yamashita, Akari Murakami, Kumiko Okujima, Kana Takemoto, Megumi Takaoka, Erina Kusakabe, Reina Aoki, Kana Taguchi, Kanako Nishiyama, Riko Kitazawa, Yoshiaki Kamei, Yasutsugu Takada
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 1175-1181 (2021)
A 34-year-old woman with a rapidly growing right breast mass visited our hospital. The mass was diagnosed as a right breast cancer (cT3N1M0 stage ⦀A). Her serum leucocyte count and C-reactive protein levels were high, and she had persistent fever.
Externí odkaz:
https://doaj.org/article/adaf1817fe2341b88715f7da32f87003
Autor:
Michiko Yamashita, Yoshiaki Kamei, Akari Murakami, Erina Ozaki, Kumiko Okujima, Kana Takemoto, Megumi Takaoka, Daiki Tsukamoto, Erina Kusakabe, Tomoyuki Shidahara, Haruna Noda, Reina Aoki, Kana Taguchi, Kanako Nishiyama, Mariko Eguchi, Yasutsugu Takada
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-5 (2021)
Abstract Background Metaplastic carcinoma of the breast consists of both invasive ductal carcinoma and metaplastic carcinoma. This rare subtype of cancer has a poor prognosis. The development of metaplastic breast cancer and relationship with BRCA1 a
Externí odkaz:
https://doaj.org/article/8805da2c65e44a08b0bbc29a48c0e055
Autor:
Kana Kobayashi-Taguchi, Takashi Saitou, Yoshiaki Kamei, Akari Murakami, Kanako Nishiyama, Reina Aoki, Erina Kusakabe, Haruna Noda, Michiko Yamashita, Riko Kitazawa, Takeshi Imamura, Yasutsugu Takada
Publikováno v:
Molecules, Vol 27, Iss 10, p 3340 (2022)
Fibroadenomas (FAs) and phyllodes tumors (PTs) are major benign breast tumors, pathologically classified as fibroepithelial tumors. Although the clinical management of PTs differs from FAs, distinction by core needle biopsy diagnoses is still challen
Externí odkaz:
https://doaj.org/article/5c516d29c5ea4df8990f41ee1ac5e44b
Autor:
Kanako Nishiyama, Masashi Maekawa, Akari Murakami, Kaho Utsunomiya, Kana Takemoto, Erina Kusakabe, Haruna Noda, Reina Aoki, Kana Taguchi, Michiko Yamashita, Tomoya Nakagita, Jun Nakayama, Mami Chosei, Takeshi Kiyoi, Yoshiaki Kamei, Hiroyuki Takeda, Yasutsugu Takada, Shigeki Higashiyama
Publikováno v:
Cancer Research. 82:P5-10
Overexpression of human epidermal growth factor receptor 2 (HER2) in breast cancer is correlated with poor prognosis. HER2-targeting drugs have been successful to treat HER2-positive breast cancer. However, the acquisition of the drug resistance with
Autor:
Haruna Noda, Yasutsugu Takada, Akari Murakami, Riko Kitazawa, Michiko Yamashita, Takeshi Imamura, Takashi Saitou, Kana Kobayashi-Taguchi, Kanako Nishiyama, Yoshiaki Kamei, Erina Kusakabe, Reina Aoki
Publikováno v:
Molecules; Volume 27; Issue 10; Pages: 3340
Background Fibroadenomas (FAs) and phyllodes tumors (PTs) are major benign breast tumors. They are pathologically classified as fibroepithelial tumors, composed of a proliferation of both epithelial and stroma. Although the clinical management of PTs
Autor:
Daiki Tsukamoto, Mariko Eguchi, Akari Murakami, Erina Ozaki, Kana Taguchi, Kanako Nishiyama, Tomoyuki Shidahara, Michiko Yamashita, Yasutsugu Takada, Haruna Noda, Kumiko Okujima, Erina Kusakabe, Kana Takemoto, Megumi Takaoka, Yoshiaki Kamei, Reina Aoki
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-5 (2021)
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice
Background Metaplastic carcinoma of the breast consists of both invasive ductal carcinoma and metaplastic carcinoma. This rare subtype of cancer has a poor prognosis. The development of metaplastic breast cancer and relationship with BRCA1 are not we
Autor:
Kanako NISHIYAMA, Erina KUSAKABE, Tomohiro SHIDAHARA, Kana TAGUCHI, Riko KITAZAWA, Yoshiaki KAMEI, Yasutugu TAKADA
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 82:1303-1309
Autor:
Michiko Yamashita, Kanako Nishiyama, Mana Fukushima, Akari Murakami, Yoshiaki Kamei, Erina Kusakabe
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 81:2186-2191
Autor:
Michiko Yamashita, Kana Taguchi, Erina Kusakabe, Reina Aoki, S Komatsu, K Kawai, Yoshiaki Kamei, N Araki, Yoshikazu Takada, J Nakayama, Akari Murakami, Shigeki Higashiyama, M Maekawa, Wakana Sugimori, Haruna Yamasawa, T Taguchi, Kanako Nishiyama, Kentaro Semba
Publikováno v:
Cancer Research. 79:P1-05
Overexpression of HER2 in breast cancer is correlated with poor prognosis. HER2-targeted drugs, such as trastuzumab and lapatinib, have been successful to treat HER2-positive breast cancers, however, the acquisition of the drug resistance of the cell